MDX2301

· ModeX Therapeutics, An OPKO Health Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDX2301, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating MDX2301 in Healthy Adults and Adults at Higher Risk for Severe COVID-19. [Phase 1]